Clorox is Dealing With Several Years of Challenging Circumstances | CLX Stock Analysis
1 extracted signal · 0 resolved · 1 still active
Parkev Tatevosian, CFAIndependent analyst profile- Source published
- 02 Oct 2026, 15:45 UTC
- Recorded by Tahlil Plus
- 02 Oct 2026, 19:59 UTC
AI-generated source summary
The analysis presents Clorox (CLX) as a potentially undervalued stock. The company's revenue surged during the pandemic but has since declined, with profit margins dropping from a peak of 23% to 9.11%. Return on invested capital has also fallen but remains above 10%. The current forward PE ratio is 12.99, which is stated to be historically low. The intrinsic value is estimated at $110.82, suggesting a 34.99% upside from the current market price of $81.35. The stock is considered a 'Buy' with a medium conviction level. The fail bound is set at $70.00, below which the bullish thesis would be invalidated.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Source processing completed
Source analysis and structured extraction completed.
- Live evaluation in progress
1 signal remains active.
Parkev Tatevosian, CFA
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.